Cargando…

Prominent T-Cell Responses against the Acetylcholine Receptor ε Subunit in Myasthenia Gravis

The human acetylcholine receptor (AChR) is well characterized as the target antigen in myasthenia gravis (MG). Pathogenic antibody responses against the AChR alpha-chain have been investigated extensively and are of diagnostic and prognostic value. However, less is known on the pathogenetic relevanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neuhaus, Oliver, Wiesmüller, Karl-Heinz, Hartung, Hans-Peter, Wiendl, Heinz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421006/ https://www.ncbi.nlm.nih.gov/pubmed/30941215 http://dx.doi.org/10.1155/2019/1969068

Ejemplares similares

Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis
por: Keller, Christian W., et al.
Publicado: (2021)

Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence
por: Vu, Tuan, et al.
Publicado: (2023)

IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis(†)
por: Leite, Maria Isabel, et al.
Publicado: (2008)

The Anti-Acetylcholine Receptor Antibody Test in Suspected Ocular Myasthenia Gravis
por: Lee, Jung Jin, et al.
Publicado: (2014)

Pathogenetic Significance of Fetal-Type Acetylcholine Receptors on Thymic Myoid Cells in Myasthenia Gravis
por: Geuder, Kerstin I., et al.
Publicado: (1992)

Eculizumab versus rituximab in generalised myasthenia gravis
por: Nelke, Christopher, et al.
Publicado: (2022)

Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development
por: Heldal, Anne Taraldsen, et al.
Publicado: (2014)

Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis
por: Ayzenberg, Ilya, et al.
Publicado: (2019)

Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis
por: Obaid, Abeer H., et al.
Publicado: (2022)

A Striational Muscle Antigen and Myasthenia Gravis-Associated Thymomas Share an Acetylcholine-Receptor Epitope
por: Marx, Alexander, et al.
Publicado: (1992)

Possible implications of dysregulated nicotinic acetylcholine receptor diffusion and nanocluster formation in myasthenia gravis
por: Barrantes, Francisco J.
Publicado: (2020)

The association between anti‐acetylcholine receptor antibody level and clinical improvement in myasthenia gravis
por: Marcuse, Florit, et al.
Publicado: (2022)

A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia Gravis
por: Lazaridis, Konstantinos, et al.
Publicado: (2022)

Induction of acetylcholine receptor-specific suppression. An in vitro model of antigen-specific immunosuppression in myasthenia gravis
Publicado: (1984)

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
por: Park, Kee Hong, et al.
Publicado: (2018)

Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
por: Katyal, Nakul, et al.
Publicado: (2021)

Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies
Publicado: (1976)

Significance of Acetylcholine Receptor Antibody Titers in Acetylcholine Receptor Antibody-Positive Ocular Myasthenia Gravis: Generalization and Presence of Thyroid Autoimmune Antibodies and Thymoma
por: Supawongwattana, Montana, et al.
Publicado: (2023)

Myasthenia gravis and acetylcholine receptor antibodies: A clinico immunological correlative study on South Indian patients
por: Bindu, P. S., et al.
Publicado: (2008)

Correction: Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
por: Park, Kee Hong, et al.
Publicado: (2018)

Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys
por: Losen, Mario, et al.
Publicado: (2017)

C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis
por: Aguirre, Florencia, et al.
Publicado: (2020)

Retrospective Analysis of Eculizumab in Patients with Acetylcholine Receptor Antibody-Negative Myasthenia Gravis: A Case Series
por: Datta, Sorabh, et al.
Publicado: (2020)

Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis
Publicado: (1976)

Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis
por: Stascheit, Frauke, et al.
Publicado: (2022)

Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale
por: Barnett, Carolina, et al.
Publicado: (2015)

Detecting myasthenia gravis as a cause of unclear dysphagia with an endoscopic tensilon test
por: Warnecke, Tobias, et al.
Publicado: (2021)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Acetylcholine receptor antibody-positive myasthenia gravis associated with small-cell lung cancer: A case report
por: Yamasaki, Masahiro, et al.
Publicado: (2018)

Acetylcholine Receptor-Antibody-Positive Myasthenia Gravis Presenting with Early Atrophy and Nonfluctuating Weakness of Proximal Limb Muscles
por: Pancheri, Elia, et al.
Publicado: (2020)

Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability
por: Takamori, Masaharu
Publicado: (2020)

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab
por: Vissing, John, et al.
Publicado: (2020)

Effect of Buzhong Yiqi decoction on anti-acetylcholine receptor antibody and clinical status in juvenile ocular myasthenia gravis
por: Li, Jiaduo, et al.
Publicado: (2021)

Immunoregulatory Cells in Myasthenia Gravis
por: Wu, Ying, et al.
Publicado: (2020)

Late-onset Myasthenia Gravis Accompanied by Amyotrophic Lateral Sclerosis with Antibodies against the Acetylcholine Receptor and Low-density Lipoprotein Receptor-related Protein 4
por: Ohnari, Keiko, et al.
Publicado: (2018)

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
por: Muppidi, Srikanth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ohdcp7i3cfiujgiddvhtfvk3vf